102 related articles for article (PubMed ID: 14681842)
1. Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial.
Clement S; Dandona P; Still JG; Kosutic G
Metabolism; 2004 Jan; 53(1):54-8. PubMed ID: 14681842
[TBL] [Abstract][Full Text] [Related]
2. Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.
Kipnes M; Dandona P; Tripathy D; Still JG; Kosutic G
Diabetes Care; 2003 Feb; 26(2):421-6. PubMed ID: 12547873
[TBL] [Abstract][Full Text] [Related]
3. Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.
Clement S; Still JG; Kosutic G; McAllister RG
Diabetes Technol Ther; 2002; 4(4):459-66. PubMed ID: 12396740
[TBL] [Abstract][Full Text] [Related]
4. Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjects.
Wajcberg E; Miyazaki Y; Triplitt C; Cersosimo E; DeFronzo RA
Diabetes Care; 2004 Dec; 27(12):2868-73. PubMed ID: 15562199
[TBL] [Abstract][Full Text] [Related]
5. Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia.
DiCostanzo CA; Moore MC; Lautz M; Scott M; Farmer B; Everett CA; Still JG; Higgins A; Cherrington AD
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E46-52. PubMed ID: 15713685
[TBL] [Abstract][Full Text] [Related]
6. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
8. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
9. Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy.
Kordonouri O; Hartmann R; Remus K; Bläsig S; Sadeghian E; Danne T
Pediatr Diabetes; 2012 Nov; 13(7):540-4. PubMed ID: 22765260
[TBL] [Abstract][Full Text] [Related]
10. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
[TBL] [Abstract][Full Text] [Related]
11. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
[TBL] [Abstract][Full Text] [Related]
12. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
13. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
[TBL] [Abstract][Full Text] [Related]
14. Impact of dietary protein on postprandial glycaemic control and insulin requirements in Type 1 diabetes: a systematic review.
Paterson MA; King BR; Smart CEM; Smith T; Rafferty J; Lopez PE
Diabet Med; 2019 Dec; 36(12):1585-1599. PubMed ID: 31454430
[TBL] [Abstract][Full Text] [Related]
15. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
Dimitriadis GD; Tessari P; Go VL; Gerich JE
Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
[TBL] [Abstract][Full Text] [Related]
16. Postprandial glucose and insulin levels in type 2 diabetes mellitus patients after consumption of ready-to-eat mixed meals.
Manios Y; Moschonis G; Mavrogianni C; Tsoutsoulopoulou K; Kogkas S; Lambrinou CP; Efstathopoulou E
Eur J Nutr; 2017 Apr; 56(3):1359-1367. PubMed ID: 26919992
[TBL] [Abstract][Full Text] [Related]
17. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
18. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
[TBL] [Abstract][Full Text] [Related]
19. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
20. Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.
Bartolo PD; Pellicano F; Scaramuzza A; Sardu C; Casetti T; Bosi E; Miselli V; Brandolini S; Fabbri T; Meandri P; Cannatà F
Diabetes Technol Ther; 2008 Dec; 10(6):495-8. PubMed ID: 19049379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
